£795.00

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 3 months

2023-2028 World Outlook for Viral Infections - Global Market Report

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 37 days · 37 data points (no recent data)

Historical
Generating forecast…
£795.00 £755.25 £771.15 £787.05 £802.95 £818.85 £834.75 23 August 2026 01 September 2026 10 September 2026 19 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 54 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 37 days • 1 price levels

Days at Price
37 days 0 9 19 28 37 £795 Days at Price

Price Analysis

Most common price: £795 (37 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 37 days

Description

This comprehensive market research report analyses the global outlook for viral infections across more than 190 countries, providing detailed demand forecasts and industry earnings projections through 2028. The study delivers latent demand estimates measured in millions of U.S. dollars for each country, alongside comparative benchmarks showing each nation's share within its region and the global market. Using advanced econometric models, the report projects fundamental economic dynamics across countries to forecast viral infection market trends. Readers gain actionable insights into market size, growth potential, and competitive positioning across territories, enabling strategic decision-making for healthcare, pharmaceutical, and public health sectors planning for viral infection management and preparedness.

Key Features

The 2023-2028 World Outlook for Viral Infections covers market data across more than 190 countries with year-by-year estimates.

Latent demand and potential industry earnings (P.I.E.) figures are provided in millions of U.S. dollars for precise financial benchmarking.

Country-level data includes percentage share metrics relative to regional and global markets for competitive analysis.

Econometric models project fundamental economic dynamics within and across countries to forecast viral infection market trends.

Comparative benchmarks allow rapid assessment of each country's viral infections market position against others globally.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
10 May 2022
Listed Since
15 May 2022

Similar Products You Might Like

The 2023-2028 World Outlook for Virology
95% match

The 2023-2028 World Outlook for Virology

£795.00 12 Nov 2026
The 2027-2032 World Outlook for Virology
93% match

The 2027-2032 World Outlook for Virology

£890.00 12 Nov 2026
The 2023-2028 World Outlook for Generic Antiviral Drugs
92% match

The 2023-2028 World Outlook for Generic Antiviral Drugs

£795.00 15 Sep 2026
The 2026-2031 World Outlook for Virology
92% match

The 2026-2031 World Outlook for Virology

£885.00 12 Nov 2026
The 2023 Report on Viral Infection Treatments: World Market Segmentation by City
92% match

The 2023 Report on Viral Infection Treatments: World Market Segmentation by City

£795.00 15 Sep 2026
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States
91% match

The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States
90% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 World Outlook for Therapeutic Cancer Vaccines
90% match

The 2023-2028 World Outlook for Therapeutic Cancer Vaccines

£795.00 13 Sep 2026
The 2023-2028 Outlook for Biologic Vasculitis Treatments in the United States
89% match

The 2023-2028 Outlook for Biologic Vasculitis Treatments in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Herpes Simplex Virus Infections for US Zip Codes
89% match

The 2023-2028 Outlook for Herpes Simplex Virus Infections for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for HPV and CMV Therapeutics in the United States
89% match

The 2023-2028 Outlook for HPV and CMV Therapeutics in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Hepatitis Drugs in the United States
89% match

The 2023-2028 Outlook for Hepatitis Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 World Outlook for Pharma Contract Sales
89% match

The 2023-2028 World Outlook for Pharma Contract Sales

£795.00 15 Sep 2026
The 2023-2028 Outlook for Hepatitis Therapeutics in the United States
89% match

The 2023-2028 Outlook for Hepatitis Therapeutics in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs for US Zip Codes
89% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Genital Herpes Treatments in the United States
89% match

The 2023-2028 Outlook for Genital Herpes Treatments in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Vasculitis Treatments in India
89% match

The 2023-2028 Outlook for Vasculitis Treatments in India

£515.00 27 Sep 2026
2023-2028 World Outlook for Viral Culture Herpes Marker Testing
89% match

2023-2028 World Outlook for Viral Culture Herpes Marker Testing

£795.00 28 Sep 2026
The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in the United States
89% match

The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in the United States

£520.00 27 Sep 2026
The 2023-2028 World Outlook for H1N1 2009 Influenza Vaccines
89% match

The 2023-2028 World Outlook for H1N1 2009 Influenza Vaccines

£795.00 15 Sep 2026
The 2023-2028 Outlook for Biologic Vasculitis Treatments in India
89% match

The 2023-2028 Outlook for Biologic Vasculitis Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for HPV and CMV Therapeutics in India
89% match

The 2023-2028 Outlook for HPV and CMV Therapeutics in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Animal Pharmaceuticals in the United States
88% match

The 2023-2028 Outlook for Animal Pharmaceuticals in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States
88% match

The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States

£520.00 27 Sep 2026